Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Luijken

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Biometrical Journal. Biometrische Zeitschrift|May 7, 2019
Regarding "Variable selection - A review and recommendations for the practicing statistician" by G. Heinze, C. Wallisch, and D. DunklerSaskia le Cessie, Kim Luijken, Els Goetghebeur
Diagnostic and Prognostic Research|April 7, 2022
Quantitative prediction error analysis to investigate predictive performance under predictor measurement heterogeneity at model implementationKim Luijken, Jia Song, Rolf H H Groenwold
Nederlands Tijdschrift Voor Geneeskunde|July 28, 2022
[Prognostic factor identified… Now what? What we can and cannot learn from prognostic factor research]Kim Luijken, Carl K G M Moons, Maarten Van Smeeden
BMJ (Clinical Research Ed.)|May 3, 2022
Exploratory analyses in aetiologic research and considerations for assessment of credibility: mini-review of literatureKim Luijken, Olaf M Dekkers, Frits R Rosendaal, et al.
Clinical Science (London, England : 1979)|January 16, 2016
Long-term renal and cardiovascular risk after preeclampsia: towards screening and preventionNina D Paauw, Kim Luijken, Arie Franx, et al.
Pharmacoepidemiology and Drug Safety|May 13, 2020
Quality of reporting of drug exposure in pharmacoepidemiological studiesMirjam Hempenius, Kim Luijken, Anthonius de Boer, et al.
Biometrical Journal. Biometrische Zeitschrift|May 13, 2022
A comparison of full model specification and backward elimination of potential confounders when estimating marginal and conditional causal effects on binary outcomes from observational dataKim Luijken, Rolf H H Groenwold, Maarten van Smeden, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 14, 2024
Which heart failure patients benefit most from non-invasive telemedicine? An overview of current evidence and future directionsJorna van Eijk, Kim Luijken, Jaap Trappenburg, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practicesKim Luijken, Judith J Spekreijse, Maarten van Smeden, et al.
Pharmacoepidemiology and Drug Safety|March 22, 2023
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studiesKim Luijken, Rik van Eekelen, Helga Gardarsdottir, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biometrical Journal. Biometrische Zeitschrift|May 7, 2019
Regarding "Variable selection - A review and recommendations for the practicing statistician" by G. Heinze, C. Wallisch, and D. DunklerSaskia le Cessie, Kim Luijken, Els Goetghebeur
Diagnostic and Prognostic Research|April 7, 2022
Quantitative prediction error analysis to investigate predictive performance under predictor measurement heterogeneity at model implementationKim Luijken, Jia Song, Rolf H H Groenwold
Nederlands Tijdschrift Voor Geneeskunde|July 28, 2022
[Prognostic factor identified… Now what? What we can and cannot learn from prognostic factor research]Kim Luijken, Carl K G M Moons, Maarten Van Smeeden
BMJ (Clinical Research Ed.)|May 3, 2022
Exploratory analyses in aetiologic research and considerations for assessment of credibility: mini-review of literatureKim Luijken, Olaf M Dekkers, Frits R Rosendaal, et al.
Clinical Science (London, England : 1979)|January 16, 2016
Long-term renal and cardiovascular risk after preeclampsia: towards screening and preventionNina D Paauw, Kim Luijken, Arie Franx, et al.
Pharmacoepidemiology and Drug Safety|May 13, 2020
Quality of reporting of drug exposure in pharmacoepidemiological studiesMirjam Hempenius, Kim Luijken, Anthonius de Boer, et al.
Biometrical Journal. Biometrische Zeitschrift|May 13, 2022
A comparison of full model specification and backward elimination of potential confounders when estimating marginal and conditional causal effects on binary outcomes from observational dataKim Luijken, Rolf H H Groenwold, Maarten van Smeden, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 14, 2024
Which heart failure patients benefit most from non-invasive telemedicine? An overview of current evidence and future directionsJorna van Eijk, Kim Luijken, Jaap Trappenburg, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practicesKim Luijken, Judith J Spekreijse, Maarten van Smeden, et al.
Pharmacoepidemiology and Drug Safety|March 22, 2023
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studiesKim Luijken, Rik van Eekelen, Helga Gardarsdottir, et al.
Pageof 4